See all locations for this study
Phase 1Recruiting

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Sponsored by Ensem Therapeutics

About this study

Phase 1/2, open-label study of ETX-636 in participants with advanced solid tumors

Enrolling at this location

Fred Hutchinson Cancer Center

Seattle, Washington

I'm interested

This study also enrolls at 9 other locations. See all.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.